Organon (OGN) Operating Expenses (2020 - 2026)

Organon's Operating Expenses history runs 7 years deep, the most recent figure standing at $548.0 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 8.97% year-over-year to $548.0 million; the TTM figure through Mar 2026 stood at $2.1 billion (down 6.46% YoY), while the FY2025 annual figure was $2.2 billion, down 3.45% from the prior year.
• Operating Expenses was $548.0 million for Q1 2026 at Organon, up from $531.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $1.5 billion in Q4 2023 to a low of $499.0 million in Q3 2025.
• Historically, Operating Expenses has averaged $966.5 million across 5 years, with a median of $1.1 billion in 2022.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses gained 15.82% in 2023, then tumbled 64.42% in 2024.
• A 5-year view of Operating Expenses shows it stood at $1.4 billion in 2022, then advanced by 8.73% to $1.5 billion in 2023, then slumped by 59.3% to $608.0 million in 2024, then fell by 12.66% to $531.0 million in 2025, then advanced by 3.2% to $548.0 million in 2026.
• The last three Operating Expenses figures came in at $548.0 million (Q1 2026), $531.0 million (Q4 2025), and $499.0 million (Q3 2025), per Business Quant data.